2022 Cancer Statistics from the American Cancer Society

Every year, the American Cancer Society releases a summary report about the incidence of cancer in the United States. See here for their 2022 report for.  Here is their conclusion:


The risk of death from cancer has decreased continuously since 1991, resulting in an overall drop of 32% and approximately 3.5 million cancer deaths averted as of 2019. This success is largely because of reductions in smoking that resulted in downstream declines in lung and other smoking-related cancers. Adjuvant chemotherapies for colon and breast cancer and combination therapies for many cancers also contributed. Progress against cancer has accelerated in the past decade because of advances in early detection, surgical techniques, and targeted therapies, despite slowing momentum for other leading causes of death. Some recent treatment breakthroughs are particularly notable because they are for historically difficult-to-treat cancers, such as metastatic melanoma and lung cancer. Also promising is a plateau in liver cancer occurrence, which is one of the most fatal cancers and was the fastest increasing malignancy just a few years ago. However, rising incidence for breast and advanced stage prostate cancers, both of which are amenable to early detection, is concerning. Even more alarming is the persistent racial, socioeconomic, and geographic disparities for highly preventable cancers that may be exacerbated by uneven access to interventions such as HPV vaccination and expanded health care. Increased investment in the broad application of existing cancer control interventions and basic and clinical research to further knowledge and advance treatment options would undoubtedly accelerate progress against cancer and mitigate racial and socioeconomic inequalities.